This is the text extract for Funding applications received since 1 July 2002, browse documents here.

---

Applications received for new investments since 1 July 2002:

As published in the Guidelines for the Pharmacology and Therapeutics Advisory Committee (PTAC) and its Subcommittees 2002, PHARMAC is, from 1 July 2002, making the existence of applications for new investments (including clinical proposals to widen access) publicly known by publishing them (including the name of the applicant) on PHARMAC’s website. As at 3 June 2008 the following applications for new investments had been received: Trade (chemical) names Lumigan (bimatoprost) Actos (pioglitazone hydrochloride) Enbrel (etanercept) Zostrix (capsaicin) cream Zostrix (capsaicin) HP cream Evista (raloxifene hydrochloride) MabThera (rituximab) Date received 15-Jul-02 12-Jul-02 12-Jul-02 20-Sep-02 20-Sep-02 30-Sep-02 9-Oct-02 Presentation Eye Drops (0.03%) Tablets (15/30/45 mg) 25 mg powder 0.025% cream 0.075% cream Tablets (60 mg) Single-use vials of 100 mg/10 ml and 500 mg/50 ml solution PEGASYS: 180 mcg and 135 mcg strength 0.5 ml solution for injection; 200 mg ribavirin tablets Tablets (10 mg and 20 mg) Applicant Allergan New Zealand Limited Eli Lilly and Company (NZ) Limited Wyeth Pty Limited AFT Pharmaceuticals Ltd AFT Pharmaceuticals Ltd Eli Lilly and Company (NZ) Limited Roche Products (New Zealand) Limited Roche Products (New Zealand) Ltd

Pegasys with Copegus (Pegylated interferon alpha 2a 14-Oct-02 in combination with ribavirin) Lexapro (aka Cipralex) (escitalopram; s-citalopram) 14-Oct-02

Lundbeck Australia Pty Ltd

7-Oct-02 (FPA) 27-Sept-02 Femidom (the female condom) (Meridian Developments) Durex Avanti (non-latex male condoms) Sep-02

Packs of 3

FPA / Meridian Developments

Packs of 5

Durex / SSL International plc

A220517 - qA9138

---

Trade (chemical) names

Date received

Presentation Packs of 6 Tablets (1 mg) Capsules (100 mg) Tablets (2.5 mg) Injection (25 mg, 37.5 mg and 50 mg strengths) Oral solution (1 mg/ml in 60 ml bottle) and tablets (1 mg in 10) Topical solution (30 ml and 60 ml for Dalacin T, 30 ml for Clinac and Topicil) 4 mg IV infusion

Applicant Meridian Developments (representing Crown Agents in NZ) AstraZeneca Limited Novartis New Zealand Limited Novartis New Zealand Limited Janssen-Cilag Pty Ltd Wyeth Pty Limited

Sagami (non-latex 27-Sep-02 (polyurethane) male condoms) Arimidex (anastrozole) Glivec (imatinib mesylate STI571) Femara (letrozole) Risperdal Consta (risperidone microspheres) Rapamune (sirolimus) 15-Oct-02 15-Oct-02 15-Oct-02 16-Oct-02 14-Oct-02

Dalacin T, Clinac, Topicil (topical clindamycin phosphate 19-Nov-02 USP 1%) Zometa (zoledronic acid) Glucoval testing strips (blood glucose testing strips) Diovan (valsartan) Co-Diovan (valsartan + hydrochlorothiazide Ezetrol (ezetimibe) Zyprexa (olanzapine) Lamictal (lamotrigine) Diason Scandishake

A220517 - qA9138

Pharmacia Limited

12-Jan-03 14-Apr-03 15-Apr-03 15-Apr-03 16-Apr-03 24-Apr-03 28-Apr-03 8-May-03 8-May-03

Novartis New Zealand Limited AFT Pharmaceuticals Ltd

Tablets (40, 80 or 160 mg) Tablets (80/15.5, 160/12.5 and 160/25 mg) Tablets (10 mg) Tablets (2.5, 5 and 10 mg) Tablets (5, 25, 50 and 100 mg) Oral supplement / complete diet (1000 ml pack) Oral supplement / complete diet (85 g sachets)

Novartis New Zealand Limited Novartis New Zealand Limited Merck Sharpe and Dohme Eli Lilly and Company (NZ) Limited GlaxoSmithKline Nutricia Nutricia

---

Trade (chemical) names Cubitan Forticreme Diasip Minaphlex Renilon 7.5 Nutrini Extra Fortini Fortini Multifibe Loprofin Loprofin Visudyne (verteporfin) ProSure Jevity Plus Jevity Hical Osmolite HN

Date received 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 8-May-03 17-Jun-03 29-Aug-03 29-Aug-03 29-Aug-03 29-Aug-03

Presentation Oral supplement (200 ml pack) Oral supplement / complete diet (125 ml tub) Oral supplement / complete diet (200 ml pack) Protein supplement (29 g sachets) Oral supplement (125 ml pack) Oral supplement / complete diet (500 ml pack) Oral supplement / complete diet (200 ml pack) Oral supplement / complete diet (200 ml pack) Breakfast cereal (375 g pack) Low protein drink mix (400 g can) Powder (15 mg) for IV infusion Oral supplement/complete diet (240 ml pack) Oral supplement/complete diet (1000 ml pack) Oral supplement/complete diet (1000 ml and 237 ml pack) Oral supplement/complete diet (1000 ml pack) 1% cream Pre-operative oral supplement (74 g sachets)

Applicant Nutricia Nutricia Nutricia Nutricia Nutricia Nutricia Nutricia Nutricia Nutricia Nutricia Novartis New Zealand Ltd. Abbott Laboratories (NZ) Limited Abbott Laboratories (NZ) Limited Abbott Laboratories (NZ) Limited Abbott Laboratories (NZ) Limited AFT Pharmaceuticals Ltd Novartis New Zealand Ltd.

Crystacide (hydrogen peroxide 17-Sep-03 1%) cream Oral Impact

A220517 - qA9138

19-Sep-03

---

Trade (chemical) names TheraTears (carboxymethylcellulose sodium solution) Seroquel (quetiapine)

Date received 29-Sep-03

Presentation Eye Drops (0.025%)

Applicant Corneal Lens Corporation

6-Oct-03

Tablets (25 mg, 100 mg, 150 mg and 200 mg)

AstraZeneca Limited

Risperdal Quicklet (risperidone)

7-Oct-03

Tablets (0.5 mg, 1.0 mg and 2.0 mg)

Janssen – Cilag Pty Ltd

Arcoxia (etoricoxib)

8-Oct-03

Tablets (60 mg, 90 mg and 120 mg)

Merck Sharpe and Dohme (New Zealand) Limited

Zyprexa Zydis (olanzapine)

13-Oct-03

Wafers (5 mg and 10 mg)

Eli Lilly New Zealand Limited

Crestor (rosuvastatin)

23-Dec-03

Tablets (10 mg, 20 mg, 40 mg and 80 mg)

AstraZeneca Limited

Human growth hormone (somatropin)

7-Jan-04

Various

New Zealand Society of Endocrinologists

Aromasin (exemestane)

8-Jan-04

Tablets (25 mg)

Pfizer New Zealand Limited

Dilatrend (carvedilol)

13-Jan-04

Tablets (6.25 mg, 12.5 mg, 25 mg)

Roche Products (New Zealand) Limited

Gemcitabine

16-Jan-04

200 mg or 1g injection

Eli Lilly

A220517 - qA9138

---

Trade (chemical) names

Date received

Presentation Tablets (10 mg and 20 mg)

Applicant Lundbeck Australia Pty Ltd

Lexapro (escitalopram oxalate) 6-Apr-04

Oxycontin (oxycodone hydrochloride) Symbicort turbuhaler (Budesonide / eformoterol)

8-Apr-04

Tablets (10 mg, 20 mg, 40 mg and 80 mg)

Mundipharma Pty Ltd

13-Apr-04

Inhaler (80/4.5μg and 160/4.5μg)

AstraZeneca Limited

Enbrel (etanercept)

13-Apr-04

25 mg powder Paclitaxel - 100 mg injection and 6 mg/ml solution for infusion Docetaxel – 20 mg and 80 mg injection, and 20 mg / 0.5 ml and 40 mg / ml solution 20 mg tablets 500 mg tablets 250 mg capsules 500 mg vials 1g/5 ml powder 50 mg capsule

Wyeth New Zealand

Taxanes

13-Apr-04

Clinicians

Paroxetine mesylate

16-Apr-04

AFT Pharmaceuticals

Mycophenolate mofetil

27-May-04

Roche

Thalidomide

31-May-04

Douglas

MabThera (rituximab)

4-Jun-04

Single-use vials of 100 mg/10 ml and 500 mg/50 ml solution

Clinicians

Oxaliplatin

9-July-04

Vials (50 mg and 100 mg)

Sanofi-Synthelabo

A220517 - qA9138

---

Trade (chemical) names Memantine

Date received 12-July-04

Presentation 10 mg tablets 10 mg/g oral drops solution 3 ml cartridge 10 ml vial 100 IU/ml

Applicant Lundbeck

Insulin glargine

13-July-04

Aventis

Rosuvastatin

23-July-2004

AstraZeneca

Docetaxel

28-Sept-04

Vials (20 mg and 80 mg)

Aventis

Pemexetred

5-Oct-04

500 mg vial

Eli Lilly

Rapamune (sirolimus)

11-Oct-04

1 mg per ml oral liquid

Wyeth

Methyl 5-aminolevulinat

11-Oct-04

160 mg/g cream

Galderma

Hepsera (adefovir dipivoxil)

11-Oct-04

10 mg tablets

Gilead

Gefitinib

11-Oct-04

250 mg capsules

AstraZeneca

Etanercept

12-Oct-04

25 mg injection

Wyeth

A220517 - qA9138

---

Trade (chemical) names Adalimumab

Date received 13-Oct-04

Presentation 50 mg/ml 0.8 ml injection

Applicant Abbott Laboratories

Methylphenidate ER

13-Oct-04

Tablets (18 mg, 36 mg and 54 mg)

Janssen-Cilag

Lanreotide acetate

13-Oct-04

Prefilled syringe (60 mg, 90 mg and 120 mg)

NZ Medical and Scientific

Lexapro (escitalopram oxalate) Combigan (brimonidine tartrate and timolol maleate) Avastin (Bevacizumab) Strattera (Atomoxetine) Reyataz (atazanavir sulfate) Viread (tenofovir disorpoxil fumarate)

23 Dec 04

10mg and 20mg film coated tablets

Lundbeck

23 Dec 04

Eye Drops (0.2% and 0.5%)

Allergan

23 Dec 04

100mg and 400mg vials

Roche

10 Jan 05

10mg, 18mg, 25mg, 40mg, or 60mg capsules

Eli Lilly

11 Jan 05

150mg or 200 mg capsules

Bristol-Myers Squibb

11 Jan 05

300mg capsules

Gilead

Tracleer (bosentan)

17 Jan 05

62.5mg and 125mg tablets

Actelion Pharmaceuticals Australia and Asia Pacific

A220517 - qA9138

---

Trade (chemical) names

Date received

Presentation 135 mcg or 180 mcg injection

Applicant Roche Products New Zealand Limited

Pegasys (pegylated interferon 4 April 05 alpha-2a)

Emtiva (emtricitabine)

4 April 05

200 mg capsules

Gilead Sciences Pty Ltd

Spiriva (tiotropium bromide)

10 April 05

18 mcg capsules (Widening access)

Boehringer Ingelheim (NZ) Ltd

Atacand (candesartan)

10 April 05

4 mg, 8 mg, 16 mg tablets (Widening access)

AstraZeneca

Fuzeon (enfuvirtide)

10 April 05

108 mg vials

Roche Products New Zealand Ltd

Xalacom (latanoprost with timolol maleate)

11 April 05

5 ml bottle containing latanoprost 50mcg/ml and timolol Pfizer New Zealand Ltd maleate 5 mg/ml Clinician (on behalf of New Zealand Liver Transplant Unit)

Pegasys (pegylated interferon 15 April 05 alpha-2a)

135mcg or 180mcg injection

Zevalin (ibritumomab)

28 April 05

3.2 mg ibritumomab tiuxetan in sodium chloride solution (2 ml)

Schering

Keppra (levetiracetam)

17 May 05

250mg, 500mg, 1000mg tablets

UCB Pharma

Xeloda (capecitabine)

17 May 05

150mg, 500mg tablets (Widening access)

Roche Products New Zealand Ltd

A220517 - qA9138

---

Trade (chemical) names Zithromax (azithromycin)

Date received 7 April 05

Presentation 500 mg tablet (Widening access)

Applicant Clinician Group

Levemir (insulin detemir)

11 July 05

3ml cartridge

Novo Nordisk

Eligard (leuprorelin acetate)

11 July 05

7.5mg, 22.5mg, 30mg depots

Mayne Pharma Pty Ltd

Suboxone (buprenorphine/naloxone) Symbicort (budesonide with eformoterol)

12 July 05

2.5mg/0.5mg, 8mg/2mg sublingual tablet

Reckitt Benckiser (NZ) Ltd

12 July 05

Dry Powder Inhaler 100/6 mcg, 200/6 mcg

AstraZeneca

Finasteride or tamsulosin

2 Sept 05

5 mg tablet (finasteride); 0.4 mg capsule (tamsulosin)

Clinicians

Androderm (testosterone patches)

21 Sept 05

2.5 mg transdermal patch

Mayne Pharma

Temodal (temozolomide)

18 Oct 05

5 mg, 20 mg, 100 mg, 250 mg capsules

Schering-Plough

Herceptin (trastuzumab)

20 Dec 05

150 mg, 440 mg injection

Roche Products New Zealand Ltd

Kivexa (abacavir with lamivudine)

4 Jan 06

600 mg abacavir with 300mg lamivudine tablet

GlaxoSmithKline

A220517 - qA9138

---

Trade (chemical) names Zoladex (goserelin acetate widen access)

Date received 4 Jan 06

Presentation 3.6 mg, 10.8 mg injection

Applicant AstraZeneca

Glucerna SR

20 Jan 06

Diabetic oral supplement 1 Kcal/ml

Abbott Nutrition

ProSure

20 Jan 06

Oral supplement for use in cancer

Abbott Nutrition

Jevity, Jevity Plus, Jevity HiCal 20 Jan 06

Adult enteral feed with fibre 1 Kcal/ml, 1.2 Kcal/ml, 1.5 Abbott Nutrition Kcal/ml Adult enteral feed with fibre 1 Kcal/ml and increased protein

Promote

20 Jan 06

Abbott Nutrition

Elecare

20 Jan 06

Elemental formulas Paediatric enteral feed with fibre 1.0 Kcal/ml; Paediatric enteral feed 1.0 Kcal/ml, 1.5 Kcal/ml; Paediatric oral feed 1.0 Kcal/ml; Paediatric oral feed with fibre 1.0 Kcal/ml Juice style adult oral supplement

Abbott Nutrition

Pediasure

20 Jan 06

Abbott Nutrition

Enlive plus

20 Jan 06

Abbott Nutrition

Nutrini Low Energy Multi Fibre 20 Jan 06

Paediatric enteral feed

Nutricia

Scandishake

20 Jan 06

Oral supplement / complete diet

Nutricia

A220517 - qA9138

---

Trade (chemical) names Aldara (imiquimod)

Date received 3 April 06

Presentation Cream Sachets 5%, 250 g

Applicant 3M Pharmaceuticals

Fabrazyme (agalsidase beta) 4 April 06

5 ml and 20 ml vials containing 5 mg and 35 mg Fabrazyme respectively.

Genzyme Australasia

Tarceva (erlotinib)

3 April 06

25 mg, 100 mg and 150 mg tablets

Roche Pharmaceuticals

Velcade (bortezomib)

5 April 06

3.5 mg in 10 mg vial – IV injection

Janssen-Cilag

Eloxatin (oxaliplatin)

7 April 06

50 mg and 100 mg vials - powder for infusion

Sanofi Aventis

Mycardis (telmisartan)

7 April 06

40 mg and 80 mg tablets

Boehringer Ingelheim

Jadelle (Levonorgestrel implants)

21 June 2006

Implants, 75 mg

Schering Plough

Alimta (Pemetrexed disodium) 30 June 2006

Injection, 500 mg

Eli Lilly

Exjade (deferasirox)

30 June 2006

Tablet 125 mg, 250 mg and 500 mg

Novartis

Enbrel (Etanercept)

4 July 2006

Injection, 25 mg

Wyeth

A220517 - qA9138

---

Trade (chemical) names Certican (everolimus)

Date received 4 July 2006

Presentation Tablet 0.25 mg, 0.50 mg, 0.75 mg and dispersible tablet 0.25 mg

Applicant Novartis

Baraclude (Entecavir)

4 July 2006

Tablet 0.5 mg and 1 mg

Bristol-Myers Squibb

Flomaxtra (Tamsulosin hydrochloride)

2 October 2006

Capsules 0.4 mg

CSL

Enbrel (Etanercept)

2 October 2006

Injection 25 mg, 50 mg

Wyeth

Movicol (Macrogol)

3 October 2006

Sachet 13.125g, Sodium chloride 350.7mg, Sodium bicarbonate 178.5mg, Potassium chloride 46.6mg

PharmaMarketing

Faslodex (Fulvestrant)

3 October 2006

250 mg / 5 ml solution

AstraZeneca

Caelyx (Pegylated liposomal doxorubicin)

3 October 2006

Injection 2 mg / ml

Schering-Plough

Humira (Adalimumab)

6 October 2006

Injection 40 mg / ml

Abbott Laboratories

Mabthera (Rituximab)

5 Dec 2006

Injection 100 mg, 500 mg

Roche Pharmaceuticals

Lexapro (Escitalopram oxalate) 5 Dec 2006

Tablet 10 mg, 20 mg

Lundbeck

A220517 - qA9138

---

Trade (chemical) names Modavigil (Modafinil) Asasantin (Dipyridamole + aspirin) / Persantin (dipyridamole) Fosamax Plus (Alendronate sodium/cholecalciferol)

Date received 6 Dec 2006

Presentation Tablet 100 mg

Applicant CSL Biotherapies

6 Dec 2006

Tablet dipyridamole 200mg + aspirin 25mg (Asasantin) Boehringer Ingelheim / dipyridamole 200mg (Persantin)

7 Dec 2006

Tablet 70 mg

Merck, Sharp & Dohme

Ritalin LA (Methylphenidate)

7 Dec 2006

Tablet 20 mg, 30 mg, 40 mg

Novartis

Revatio (Sildenafil)

7 Dec 2006

Tablet 20 mg

Pfizer

Glivec (Imatinib mesylate)

8 Dec 2006

Capsule 100 mg (widening access)

Novartis

Topamax (Topiramate)

11 Dec 2006

Tablet 25 mg, 50 mg, 100 mg and Capsule 15 mg, 25 mg

Janssen-Cilag

Sutent (Sunitinib malate)

15 Dec 2006

Capsule 12.5 mg, 25 mg, 50 mg

Pfizer

Pegatron Combination Therapy (Pegylated interferon with 12 Feb 2007 ribavirin) Paclitaxel 2 March 2007

Powder 100 mcg / 200 mg and Injection / Tablet 180 mcg / 200 mg Solution for infusion 300 mg, 30 mg and Injection 100 mg, 1 mg

Clinicians

Clinicians

A220517 - qA9138

---

Trade (chemical) names Xolair (omalizumab)

Date received 13 March 2007

Presentation Injection 150 mg / 1.2 ml

Applicant Novartis

Vesicare succinate) Reductil hydrochloride)

(solifenacin

13 March 2007

Tablet 5 mg, 10 mg

CSL Biotherapies

(sibutramine

13 March 2007

Capsule 10 mg, 15 mg

Abbott

Champix (varenicline) Zofran/Zofran Zydis (ondansetron) and Navoban (tropisetron) Cerazette (desogestrel)

13 March 2007

Tablet 0.5 mg, 1 mg

Pfizer

21 March 2007

Ondansetron: tablet/dispersible tablet 4 mg, 8 mg and Clinician Tropisetron: capsule 5 mg

12 April 2007

Tablet 75 mcg

Pharmaco

Differin (adapalene 0.1%)

11 June 2007

Topical gel and topical cream (30g at 1mg/g)

Galderma Australia

Sprycel (dasatinib)

11 June 2007

Tablet 20 mg, 50 mg, 70 mg

Bristol-Myers Squibb

Byetta (exenatide)

11 June 2007

Pre-filled injection pen 5µg (1.2 mL), 10 µg (2.4 mL)

Eli Lilly

Lucentis (ranibizumab)

12 June 2007

Solution for intravitreal injection 3.0 mg / 0.3 mL

Novartis

A220517 - qA9138

---

Trade (chemical) names Bicalutamide-Rex (bicalutamide)

Date received 12 June 2007

Presentation Tablet 50 mg

Applicant Rex Medical Ltd

Humira (adalimumab)

12 June 2007

Injection 40 mg / ml

Abbott Laboratories

MabThera (rituximab)

10 Sept 2007

Infusion 10 ml, 50 ml

NZ Rheumatology Association Roche Pharmaceuticals

/

Abilify (aripiprazole)

10 Sept 2007

Tablet 10 mg, 15 mg, 20 mg, 30 mg

Bristol-Myers Squibb

Reandron (testosterone undecanoate)

10 Sept 2007

Injection 1000 mg / 4 ml

Bayer-Schering

Emend (aprepitant)

11 Sept 2007

Capsule (1 x 125 mg + 2 x 80 mg per pack)

Merck Sharp & Dohme

Zomig (zolmitriptan)

11 Sept 2007

Nasal spray 5 mg

AstraZeneca

MabCampath (alemtuzumab)

11 Sept 2007

Infusion 30 mg

Bayer-Schering

Prezista (darunavir)

11 Sept 2007

Tablet 300 mg

Janssen-Cilag

Tykerb (lapatinib)

11 Sept 2007

Tablet 250 mg

GlaxoSmithKline

A220517 - qA9138

---

Trade (chemical) names High-strength Seretide (Salmeterol xinafoate / fluticasone propionate)

Date received 11 Sept 2007

Presentation

Applicant

Accuhaler 60 doses (fluticasone 500 mcg + salmeterol 50 mcg), Metered dose inhaler 120 doses (fluticasone GlaxoSmithKline 250 mcg + salmeterol 25 mcg) Cartridge 3 ml (25% insulin lispro + 75% insulin lispro protamine suspension) Eli Lilly

Humalog Mix25 (insulin lispro) 11 Sept 2007

Glivec (imatinib mesylate)

23 Oct 2007

Capsule 100 mg

Novartis

Oral Navelbine (vinorelbine)

7 Dec 2007

Soft capsule 20 mg, 30 mg

Pierre Fabre Medicament Australia

Nexavar (Sorafenib)

7 Dec 2007

Tablet 200 mg

Bayer NZ

Alphagan P Eye Drops (brimonidine tartrate 0.15%) Lantus SoloStar (insulin glargine) Myfortic (Mycophenolate sodium)

7 Dec 2007

Eye drops 1.5 mg/mL (5 ml bottle)

Allergan NZ

7 Dec 2007

Lantus SoloStar pen

Sanofi Aventis

7 Dec 2007

Gastro-resistant tablet 180 mg, 360 mg

Novartis

Zoladex (goserelin acetate)

7 Dec 2007

Injection 3.6 mg

AstraZeneca

Ganfort (bimatoprost 0.03% and timolol maleate 0.5%)

11 Mar 2008

Eye drops 3 ml bottle

Allergan

A220517 - qA9138

---

Trade (chemical) names Zaditen (ketotifen fumarate)

Date received 11 Mar 2008

Presentation

Applicant

Eye drops 0.25 mg/ml 5 ml packs multidose unit, 0.4 ml Novartis Ophthalmics 20 units per pack ml single dose

Januvia (sitagliptin)

11 Mar 2008

Tablet 25 mg, 50 mg, 100 mg

Merck Sharpe & Dohme

Tasigna (nilotinib)

11 Mar 2008

Capsule 200 mg

Novartis

Lantus (insulin glargine)

11 Mar 2008

Vial10 ml, cartridge 3ml x 5, SoloStar 5 x disposable pen

Sanofi Aventis

ReVia (naltrexone hydrochloride) Cymbalta (duloxetine hydrochloride)

11 Mar 2008

Tablet 50 mg

Clinician letter

3 June 2008

Capsules 30 mg and 60 mg

Eli Lilly

Sabril (vigabatrin)

3 June 2008

Tablet 500 mg

Clinician letter

Alimta (pemetrexed disodium) 3 June 2008

500 mg vial 100mg vial

Eli Lilly

Daivobet (calcipotriol and betamethasone dipropionate)

3 June 2008

Ointment. Betamethasone dipropionate 643µg/g (equivalent to 500 µg/g betamethasone) and calcipotriol CSL biotherapies 50µg/g (as calcipotriol hydrate 52.2µg/g) 3.9 mg patch Hospira

Oxytrol (oxybutynin)

3 June 2008

A220517 - qA9138

---

Trade (chemical) names Humira (adalimumab)

Date received 3 June 2008

Presentation Subcutaneous injection 40 mg

Applicant Abbott

Iodine

3 June 2008

Tablet, at least 150 µg per day

Ministry of Health

Aclasta (zoledronic acid)

3 June 2008

Bottle for intravenous infusion: 5 mg in 100mL

Novartis

Novomix (insulin aspart)

3 June 2008

30% insulin aspart and 70% insulin aspart protamine suspension for injection/infusion

Novo Nordisk

Isentress (raltegravir)

3 June 2008

Tablet 400 mg

Merck Sharp & Dohme

Exelon (rivastigmine)

3 June 2008

Patches 9 mg and 18 mg

Novartis

Optium (blood ketones)

3 June 2008

Test stips

Medica Pacifica

Sensipar (cinacalcet)

3 June 2008

Tablets 30 mg, 60 mg and 90 mg

Amgen

Potassium citrate

3 June 2008

Not specified

Clinician letter

Leflunomide

3 June 2008

Tablets 10 mg, 20 mg, and 100 mg

NZ Rheumatology association

A220517 - qA9138

---

Trade (chemical) names Glatirmer acetate Interferon beta-1-beta Interferon beta-1-alpha Norspan PSA (buprenorphine)

Date received 9 September 2008 8 September 2008 9 September 2008 9 September 2008 6 September 2008

Presentation Not specified

Applicant Multiple Sclerosis Society of NZ; Multiple Sclerosis Treatment Assessments Panel of PHARMAC Pharmaco

Patch 5 mg, 10 mg, and 20 mg

Tredaptive (extended-release nicotinic acid/laropiprant)

Tablet 1 g/20 mg

Merck Sharp & Dohme

Pradaxa (dabigatran etexilate)

Capsule 75 mg, 110 mg

Boehringer Ingelheim

Orencia (abatacept)

Vial 250 mg

Bristol-Myers Squibb

PKU cooler (phenylketoneuria 8 September protein drink) 2008 MSUD Express Cooler (maple 8 September syrup urine disease protein 2008 drink) TYR Cooler (tyrosinaemia protein drink) HCU Cooler (homocystinuria protein drink) PKU gel (phenylketonuria protein drink) 6 October 2008

Drinks 10 g / 87 ml, 15 g / 130 ml, 20 g / 174 ml

Vitaflo Australia

Drink 15 g / 130 ml

Vitaflo Australia

Drink 15 g / 130 ml

Vitaflo Australia

6 October 2008

Drink 15 g / 130 ml

Vitaflo Australia

6 October 2008

Sachet 20 g powder

Vitaflo Australia

A220517 - qA9138